Compare Chart Industries Inc (GTLS) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chart Industries Inc vs Revvity Inc — how do they compare? Chart Industries Inc trades at $209.97 (market cap $10.05B), while Revvity Inc trades at $110.75 (market cap $12.42B). The key difference: Revvity Inc is the larger of the two by market cap, and Revvity Inc pays a 0.25% dividend while Chart Industries Inc pays none. Which is the better fit depends on your goals.
| GTLS | RVTY | |
|---|---|---|
Market Cap | $10.05B | $12.42B |
Sector | Technology | Technology |
52-Week High | $209.91 | $117.75 |
52-Week Low | $167.29 | $82.26 |
Enterprise Value | $13.57B | $14.91B |
Dividend Yield | — | 0.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GTLS trades at $209.97, up 0.03% on the day, with a bullish technical outlook supported by moving averages but overbought RSI signals. The company reported $4.26B in 2025 revenue but missed earnings estimates for three consecutive quarters, with a negative net income margin of -0.62%. Recent news highlights Baker Hughes' pending $13.6B acquisition, which received conditional EU approval in July 2026, potentially driving investor optimism.
The stock's outlook is mixed: strong analyst buy consensus (54%) and acquisition prospects offer upside, but weak profitability and earnings misses pose risks. Investors should weigh the acquisition's completion against fundamental challenges like negative ROE and high P/E of 629.67, indicating premium valuation despite profitability concerns.
RVTY trades at $111.40, up 0.17% on the day, with a bullish technical signal from moving averages and recent earnings beats. The company maintains stable revenue around $2.9B with an 8.26% net income margin, though its P/E ratio of 53.53 suggests premium valuation. Recent news highlights AI integration advances and FDA clearances, supporting growth initiatives.
Outlook is cautiously optimistic with strong analyst buy ratings (51.72%) and a $111.43 consensus target, but high valuation and margin pressures pose risks. Earnings on August 4, 2026, will be critical for confirming growth trajectory amid competitive and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Chart Industries Inc
Chart Industries is a leading manufacturer of highly engineered cryogenic equipment. Its products are used throughout the liquid gas supply chain, including clean energy applications like hydrogen and LNG.
Read more on GTLS →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
